$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
Oncology
Oncology
Oncology_Medical Halo Global Medical Oncology News_Oncology Drug Therapy News
乳腺癌是什么?怎么检测出来的?用什么药治疗?
2025-10-19 11:44:20
Check Details
瑞博西尼治疗HR+/HER2乳腺癌的安全性和有效性
2025-10-19 11:44:20
Check Details
瑞博西尼在2021年纳入国家医保了吗?
2025-10-19 11:44:20
Check Details
抗癌药瑞博西尼哪里有售?价格是多少?
2025-10-19 11:44:20
Check Details
瑞博西尼治疗HR+/HER2乳腺癌患者的效果显著
2025-10-19 11:44:20
Check Details
瑞博西尼使晚期或转移性乳腺癌患者又多了一种选择
2025-10-19 11:44:20
Check Details
瑞博西尼的出现,给乳腺癌患者带来了哪些好处?
2025-10-19 11:44:20
Check Details
瑞博西尼用于治疗绝经后妇女的激素受体(HR)阳性(HER2)阴性晚期或转移性乳腺癌
2025-10-19 11:44:20
Check Details
乳腺癌靶向药瑞博西林的治疗效果显著
2025-10-19 11:44:20
Check Details
乳腺癌患者服用瑞博西林可以延长多久的生存期?
2025-10-19 11:44:20
Check Details
瑞博西利是治疗乳腺癌的抗肿瘤靶向药
2025-10-19 11:44:20
Check Details
瑞博西林可有效改善晚期乳腺癌生存期
2025-10-19 11:44:20
Check Details
1
2
...
1998
1999
2000
2001
2002
2003
2004
...
4159
4160
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Sotorasib (Lumakras): A Comprehensive Guide to the First KRAS G12C-Targeted Inhibitor
2
Comprehensive Interpretation of Osimertinib: Efficacy, Side Effects and Medication Standards
3
Sotorasib: Can the First KRAS G12C-Targeted Therapy Cure Cancer?
4
Trametinib (Mekinist): Refrigerated Storage, Fasting Administration, and BRAF Mutation Indications Explained
5
Belzutifan (Welireg): HIF-2α Inhibitor for VHL-Associated Tumors and Renal Cell Carcinoma — Dosing Phases, Survival Data, and Efficacy Insights
6
Pemigatinib vs. Anlotinib: Key Differences Between FGFR-Targeted Therapy and Multi-Target Anti-Angiogenic Treatment
7
Lapatinib: A Targeted Anticancer Agent — Not Merely Symptom Relief
8
Lapatinib: Proper Administration Guide and Key Precautions
9
Capivasertib (Truqap) Complete Medication Guide: Indications, Dosing, Safety, and Precautions
10
Cemiplimab Storage and Handling Guide
11
Mavacamten for Obstructive Hypertrophic Cardiomyopathy: Dosing Duration, Efficacy Comparison, and Long-Term Management
12
Belzutifan (Welireg): Comprehensive Guide to the First HIF-2α Inhibitor — Indications, Dosing, and Safety Monitoring